FDA Warns Against Using NuVision Pharmacy’s Compounded Products Due To Sterility Risks
August 20, 2013
Compounding a medication occurs when a trained professional mixes certain medications and supplements to fit the specific needs of a particular patient. While these medications can be extremely effective because of their personalized nature, there is also a high risk of the products becoming contaminated with bacteria, fungi, and/or viruses.
In fact, the Drug Injury Lawyers with Ferrer, Poirot & Wansbrough point out that the U.S. Food and Drug Administration has recently been cracking down on the sterility of compounding facilities across the country.
Most recently, a press release from the agency warned consumers not to take any product manufactured by NuVision Pharmacy in Dallas, Texas, due to contamination risks. Reports indicate the problems with sterility came to the agency’s attention in April of this year after receiving reports of patients becoming ill after receiving an injection that was prepared by the company. Further inspections and testing raised further concern regarding the safety and sterility of the company’s products, resulting in a recall of the two particular injections in question.
When the FDA called for the company to recall all of its products due to safety concerns though, the company refused. The FDA has now asked all medical professionals to pull the company’s products form their shelves and to not administer the drugs to patients.